Edward White
Stock Analyst at HC Wainwright & Co.
(1.21)
# 3,404
Out of 4,829 analysts
384
Total ratings
25.76%
Success rate
-10.03%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $7.54 | +337.67% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $6.47 | +162.75% | 41 | Apr 15, 2025 | |
| INZY Inozyme Pharma | Reiterates: Buy | $16 | $1.15 | +1,291.30% | 14 | Apr 10, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $6.21 | +141.55% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $1.73 | +247.83% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $1.89 | +746.56% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $2.00 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $4 | $0.36 | +1,011.11% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $2.39 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $2.08 | +861.54% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.36 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $2.12 | +654.72% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $5.23 | +378.01% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.61 | +396.89% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.06 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.61 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $33.64 | +63.50% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $10.70 | +376.64% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.91 | +140.55% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $6.02 | +831.01% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $9.41 | +229.44% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.24 | - | 12 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.11 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $0.32 | +8,680.18% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $17.42 | +72.22% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.04 | +1,053.85% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $7.54
Upside: +337.67%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $6.47
Upside: +162.75%
Inozyme Pharma
Apr 10, 2025
Reiterates: Buy
Price Target: $16
Current: $1.15
Upside: +1,291.30%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $6.21
Upside: +141.55%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $1.73
Upside: +247.83%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $1.89
Upside: +746.56%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.00
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $4
Current: $0.36
Upside: +1,011.11%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.39
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $2.08
Upside: +861.54%
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.36
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $2.12
Upside: +654.72%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $5.23
Upside: +378.01%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $1.61
Upside: +396.89%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.06
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.61
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $33.64
Upside: +63.50%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $10.70
Upside: +376.64%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $2.91
Upside: +140.55%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $6.02
Upside: +831.01%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $9.41
Upside: +229.44%
Jun 4, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.24
Upside: -
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $1.11
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $28
Current: $0.32
Upside: +8,680.18%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $17.42
Upside: +72.22%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.04
Upside: +1,053.85%